All Stories

  1. A snapshot of the ongoing clinical research on COVID-19
  2. A hepatitis C outbreak preceded the HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study
  3. Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention
  4. Near Full-length Genomic Sequencing and Molecular Analysis of HIVInfected Individuals in a Network-based Intervention (TRIP) in Athens, Greece: Evidence that Transmissions Occur More Frequently from those with High HIV-RNA
  5. Platelet and coagulation disorders in newly diagnosed patients with pulmonary arterial hypertension
  6. Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four Years
  7. Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives
  8. Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
  9. Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains
  10. Molecular characterization of HIV-1 infection in Northwest Spain (2009–2013): Investigation of the subtype F outbreak
  11. Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece
  12. Species Based Synonymous Codon Usage in Fusion Protein Gene of Newcastle Disease Virus
  13. Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity
  14. Patterns of drug resistance among newly diagnosed HIV‐1 infected patients in Greece during the last decade: the crucial role of transmission networks
  15. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
  16. Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group
  17. HIV-1 epidemic in Russia: an evolutionary epidemiology analysis
  18. Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study
  19. Socially-Integrated Transdisciplinary HIV Prevention
  20. Ultrasensitive assay for detection of minority HBV resistance mutations
  21. Limited cross-border infections in patients newly diagnosed with HIV in Europe
  22. Detailed Molecular Epidemiologic Characterization of HIV-1 Infection in Bulgaria Reveals Broad Diversity and Evolving Phylodynamics
  23. Dating the origin and dispersal of hepatitis B virus infection in humans and primates
  24. Integrating Phylodynamics and Epidemiology to Estimate Transmission Diversity in Viral Epidemics
  25. Subgenotype A1 of HBV – tracing human migrations in and out of Africa
  26. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
  27. Molecular typing of the recently expanding subtype B HIV-1 epidemic in Romania: Evidence for local spread among MSMs in Bucharest area
  28. Assessment of phylogenetic sensitivity for reconstructing HIV-1 epidemiological relationships
  29. Appearance of a Single Amino Acid Insertion at Position 33 in HIV Type 1 Protease Under a Lopinavir-Containing Regimen, Associated with Reduced Protease Inhibitor Susceptibility
  30. HBV viremia in newborns of HBsAg(+) predominantly Caucasian HBeAg(−) mothers
  31. HIV Transmission Patterns Among The Netherlands, Suriname, and The Netherlands Antilles: A Molecular Epidemiological Study
  32. Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece
  33. Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe
  34. Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA
  35. The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis
  36. Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test
  37. Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in Europe
  38. Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications
  39. Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV‐Infected Individuals: A Cohort Study and Meta‐Analysis
  40. Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
  41. The Role of HIV-1 DNA as an Additional Marker of HIV-1 Infection
  42. Molecular characterization of occult hepatitis B cases in Greek blood donors
  43. HIV epidemiology in Greece
  44. Comments on “The distribution of HIV-1 recombination breakpoints” by Jun Fan, Matteo Negroni, David L. Robertson
  45. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection
  46. Emergence of an NNRTI Resistance Mutation Y181C in an HIV-Infected NNRTI-Naive Patient
  47. Increasing Prevalence of HIV‐1 Subtype A in Greece: Estimating Epidemic History and Origin
  48. Short Communication: Dynamics of Drug-Resistant HIV-1 in Plasma and Peripheral Blood Cells in Patients during and after Enfuvirtide Therapy
  49. Analysing the evolutionary history of HCV: Puzzle of ancient phylogenetic discordance
  50. 409 dating the HCV3a epidemic in greece using molecular clock approaches
  51. Re-analysis of 34 full-length HIV-1 intersubtype recombinant sequences
  52. Re-analysis of a human hepatitis B virus (HBV) isolate from an East African wild born Pan troglodytes schweinfurthii: Evidence for interspecies recombination between HBV infecting chimpanzee and human
  53. Analysis of complex HIV-1 intersubtype recombinants using a Bayesian scanning method
  54. Web Service-Enabled Grid-Based Platform for Drug Resistance Management
  55. SlidingBayes: exploring recombination using a sliding window approach based on Bayesian phylogenetic inference
  56. Phylogenetic Reconstruction of a Known HIV-1 CRF04_cpx Transmission Network Using Maximum Likelihood and Bayesian Methods
  57. Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion
  58. Analysis of the Evolutionary Relationships of HIV-1 and SIVcpz Sequences Using Bayesian Inference: Implications for the Origin of HIV-1
  59. High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid
  60. Genetic Evolution of Human Immunodeficiency Virus Type 1 in Two Spouses Responding Successfully to Highly Active Antiretroviral Therapy
  61. A viral kinetic study using pegylated interferon alpha 2b and lamivudine in naive patients with HBeAg(−)/I-BV-DNA(+) chronic hepatitis B: preliminary results
  62. Prevalence and genotypic distribution of TT virus in Athens, Greece*
  63. Development of a novel real-time PCR assay for the quantitation of HBV DNA
  64. Development of a novel real-time PCR assay for the quantitation of HBV DNA
  65. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma
  66. Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece
  67. Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients
  68. Prevalence patterns and genotypes of GB Virus C/hepatitis G virus among imprisoned intravenous drug users
  69. Prevalence patterns and genotypes of GB Virus C/hepatitis G virus among imprisoned intravenous drug users
  70. Genotypic Characterization of Human Immunodeficiency Virus Type 1 in Greece
  71. The global spread of Hepatitis C Virus
  72. The Global Dynamics and Spread of Hepatitis C Virus 1a and 1b: A Phylogeographical Analysis